GlassScriptPhysician profile
Donell B Oliver
NPI 1285679787
$797.35
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $44.64 · 2021: $93.06 · 2022: $177 · 2023: $119 · 2024: $90.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.64 | 2021-2023 | |
| Allergan, INC. | $151.06 | 2019 | |
| Hologic Sales and Service, LLC | $60.74 | 2023-2024 | Aptima, Omni Hysteroscope, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $60.00 | 2019-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $55.13 | 2019-2021 | |
| Organon LLC | $52.15 | 2023-2024 | Nexplanon |
| Avanos Medical | $27.40 | 2020 | |
| Bausch Health US, LLC | $23.87 | 2022 | |
| Astellas Pharma US INC | $19.13 | 2024 | Veozah |
| Biogen, INC. | $14.52 | 2024 | Zurzuvae |
| Avion Pharmaceuticals | $13.03 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.46 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.39 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.45 | 2019 | |
| Merck Sharp & Dohme LLC | $11.35 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donell Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.